What's new

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 36, Status: Authorised

Apr 28, 2025 - 14:06
 0
Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 36, Status: Authorised
Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 36, Status: Authorised
Read More

Tags:

Previous Article

The case against cancer surveillance — for some

Next Article

Umbro revives Drill Top after three decades

Related Posts

Vaccine-preventable diseases: key facts

Vaccine-preventable diseases: key facts

Apr 28, 2025  0

EU Implementation Guide (IG) on veterinary medicines pr...

Apr 26, 2025  0

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0